Protagenic Therapeutics Correlations
PTIX Stock | USD 0.38 0.04 9.52% |
The current 90-days correlation between Protagenic Therapeutics and Zivo Bioscience is 0.07 (i.e., Significant diversification). The correlation of Protagenic Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Protagenic Therapeutics Correlation With Market
Good diversification
The correlation between Protagenic Therapeutics and DJI is -0.02 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Protagenic Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Protagenic |
Moving together with Protagenic Stock
0.71 | INZY | Inozyme Pharma | PairCorr |
0.63 | KRYS | Krystal Biotech | PairCorr |
0.66 | MREO | Mereo BioPharma Group | PairCorr |
0.67 | PDSB | PDS Biotechnology Corp | PairCorr |
0.7 | ABOS | Acumen Pharmaceuticals | PairCorr |
0.61 | ADAP | Adaptimmune Therapeutics | PairCorr |
0.73 | AFMD | Affimed NV | PairCorr |
0.62 | AGIO | Agios Pharm | PairCorr |
0.74 | AMLX | Amylyx Pharmaceuticals | PairCorr |
0.61 | STOK | Stoke Therapeutics | PairCorr |
0.72 | TERN | Terns Pharmaceuticals Buyout Trend | PairCorr |
0.66 | CRVS | Corvus Pharmaceuticals | PairCorr |
0.69 | DAWN | Day One Biopharmaceu | PairCorr |
Moving against Protagenic Stock
0.68 | MLAB | Mesa Laboratories Earnings Call This Week | PairCorr |
0.31 | GILD | Gilead Sciences Earnings Call This Week | PairCorr |
0.52 | BPMC | Blueprint Medicines Corp Sell-off Trend | PairCorr |
0.34 | PTCT | PTC Therapeutics | PairCorr |
0.71 | AVAL | Grupo Aval | PairCorr |
0.7 | MNPR | Monopar Therapeutics | PairCorr |
0.64 | FNMFO | Federal National Mortgage | PairCorr |
0.54 | CIB | Bancolombia SA ADR | PairCorr |
0.42 | ITCL | Banco Ita Chile | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Protagenic Stock performing well and Protagenic Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Protagenic Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
SBHMY | 0.80 | (0.32) | 0.00 | 1.88 | 0.00 | 0.14 | 9.00 | |||
ZIVO | 3.01 | (0.57) | 0.00 | 0.71 | 0.00 | 5.31 | 36.36 | |||
CYT | 2.76 | 0.61 | 0.13 | (1.25) | 2.57 | 10.00 | 36.14 | |||
ELDN | 4.07 | 0.54 | 0.11 | 1.10 | 4.06 | 10.98 | 28.12 | |||
RZLT | 2.86 | (0.09) | 0.00 | (0.05) | 0.00 | 6.80 | 19.56 | |||
XOMAO | 0.23 | 0.01 | (0.28) | (0.61) | 0.24 | 0.52 | 1.48 | |||
TPST | 3.20 | (0.23) | 0.00 | (0.04) | 0.00 | 5.56 | 24.26 | |||
AVTE | 1.98 | 0.37 | 0.15 | 8.85 | 1.55 | 5.53 | 18.16 | |||
ADAG | 3.72 | (0.52) | 0.00 | 2.80 | 0.00 | 5.26 | 41.45 |
Protagenic Therapeutics Corporate Executives
Elected by the shareholders, the Protagenic Therapeutics' board of directors comprises two types of representatives: Protagenic Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Protagenic. The board's role is to monitor Protagenic Therapeutics' management team and ensure that shareholders' interests are well served. Protagenic Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Protagenic Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.